期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Hepatitis B virus subgenotype F3 reactivation with vaccine escape mutations:A case report and review of the literature 被引量:2
1
作者 Stefan Schlabe Kathrin van Bremen +7 位作者 Souhaib Aldabbagh Dieter Glebe Corinna M Bremer Tobias Marsen Walter Mellin Veronica Di Cristanziano Anna M Eis-Hübinger Ulrich Spengler 《World Journal of Hepatology》 CAS 2018年第7期509-516,共8页
Hepatitis B represents a global health threat because its chronic course and sequelae contribute to a high morbidity and mortality. Hepatitis B virus(HBV) infection can be controlled by vaccines, antiviral treatment, ... Hepatitis B represents a global health threat because its chronic course and sequelae contribute to a high morbidity and mortality. Hepatitis B virus(HBV) infection can be controlled by vaccines, antiviral treatment, and by interrupting transmission. Rare vaccine escape mutants are serious because they eliminate vaccine protection. Here, we present a 74-year-old vaccinated patient with HBV reactivation 11 years after kidney transplantation. The patient was HBV-positive but HBs Ag-negative prior to vaccination 6 years before transplantation. The reactivated virus was HBV genotype F3 with vaccine escape mutations G145 R, P120 Q, and Q129 P. The patient was successfully treated with entecavir. The epidemiological reasons for this subgenotype, which is extremely rare in Western Europe, were unclear. This case illustrates that second-generation vaccines are not always effective in a specific group of patients. 展开更多
关键词 ENTECAVIR Hepatitis B virus SUBGENOTYPE F3 Kidney transplantation VACCINE ESCAPE mutant G145R
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部